Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal and Gastric Cancers
NCT00439608Phase 2Completed
- Sponsor
- Brown University
- Start
- Oct 2004
- Primary completion
- Apr 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in esophageal cancer, gastric cancer (GC), gastroesophageal junction cancer, sponsored by Brown University. Started Oct 2004; status: completed.
02
Drugs
KL-140
03
Conditions
esophageal cancergastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT00439608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439608.